180 related articles for article (PubMed ID: 26334294)
1. Survival Outcomes and Pathologic Features Among Breast Cancer Patients Who Have Developed a Contralateral Breast Cancer.
Liederbach E; Wang CH; Lutfi W; Kantor O; Pesce C; Winchester DJ; Yao K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S412-21. PubMed ID: 26334294
[TBL] [Abstract][Full Text] [Related]
2. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.
Vichapat V; Garmo H; Holmberg L; Fentiman IS; Tutt A; Gillett C; Lüchtenborg M
Breast Cancer Res Treat; 2011 Nov; 130(2):609-18. PubMed ID: 21671018
[TBL] [Abstract][Full Text] [Related]
4. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and time interval analysis of contralateral breast cancers.
Liederbach E; Piro R; Hughes K; Watkin R; Wang CH; Yao K
Surgery; 2015 Sep; 158(3):676-85. PubMed ID: 26067460
[TBL] [Abstract][Full Text] [Related]
6. Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study.
Vichapat V; Garmo H; Holmqvist M; Liljegren G; Wärnberg F; Lambe M; Fornander T; Adolfsson J; Lüchtenborg M; Holmberg L
J Clin Oncol; 2012 Oct; 30(28):3478-85. PubMed ID: 22927521
[TBL] [Abstract][Full Text] [Related]
7. Inferior survival for young patients with contralateral compared to unilateral breast cancer: a nationwide population-based study in the Netherlands.
Font-Gonzalez A; Liu L; Voogd AC; Schmidt MK; Roukema JA; Coebergh JW; de Vries E; Soerjomataram I
Breast Cancer Res Treat; 2013 Jun; 139(3):811-9. PubMed ID: 23760860
[TBL] [Abstract][Full Text] [Related]
8. The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy.
Abdalla I; Thisted RA; Heimann R
Cancer J; 2000; 6(4):266-72. PubMed ID: 11038147
[TBL] [Abstract][Full Text] [Related]
9. Contralateral breast cancer: a clinico-pathological study of second primaries in opposite breasts after treatment of breast malignancy.
Shankar A; Roy S; Malik A; Kamal VK; Bhandari R; Kishor K; Mahajan M; Sachdev J; Jeyaraj P; Rath G
Asian Pac J Cancer Prev; 2015; 16(3):1207-11. PubMed ID: 25735357
[TBL] [Abstract][Full Text] [Related]
10. Contralateral breast cancer: clinical characteristics and impact on prognosis.
Healey EA; Cook EF; Orav EJ; Schnitt SJ; Connolly JL; Harris JR
J Clin Oncol; 1993 Aug; 11(8):1545-52. PubMed ID: 8336193
[TBL] [Abstract][Full Text] [Related]
11. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study.
Al-Husseini MJ; Mohamed HH; Saad AM; Gad MM; Atia M; Qaddoora U; Abushouk AI; El-Shinawi M
Curr Probl Cancer; 2019 Jun; 43(3):213-221. PubMed ID: 30195804
[TBL] [Abstract][Full Text] [Related]
12. Hormone receptor-negative breast cancer: undertreatment of patients over 80.
Weiss A; Noorbakhsh A; Tokin C; Chang D; Blair SL
Ann Surg Oncol; 2013 Oct; 20(10):3274-8. PubMed ID: 23838924
[TBL] [Abstract][Full Text] [Related]
13. Mortality after contralateral breast cancer in Denmark.
Langballe R; Frederiksen K; Jensen MB; Andersson M; Cronin-Fenton D; Ejlertsen B; Mellemkjær L
Breast Cancer Res Treat; 2018 Sep; 171(2):489-499. PubMed ID: 29948403
[TBL] [Abstract][Full Text] [Related]
14. Tumor response ratio predicts overall survival in breast cancer patients treated with neoadjuvant chemotherapy.
Miller M; Ottesen RA; Niland JC; Kruper L; Chen SL; Vito C
Ann Surg Oncol; 2014 Oct; 21(10):3317-23. PubMed ID: 25059788
[TBL] [Abstract][Full Text] [Related]
15. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
[TBL] [Abstract][Full Text] [Related]
16. Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis.
Chen AC; Paulino AC; Schwartz MR; Rodriguez AA; Bass BL; Chang JC; Teh BS
Clin Breast Cancer; 2013 Apr; 13(2):133-9. PubMed ID: 23246269
[TBL] [Abstract][Full Text] [Related]
17. Left-Sided Breast Irradiation does not Result in Increased Long-Term Cardiac-Related Mortality Among Women Treated with Breast-Conserving Surgery.
Paul Wright G; Drinane JJ; Sobel HL; Chung MH
Ann Surg Oncol; 2016 Apr; 23(4):1117-22. PubMed ID: 26530446
[TBL] [Abstract][Full Text] [Related]
18. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.
Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K
Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base.
Greif JM; Pezzi CM; Klimberg VS; Bailey L; Zuraek M
Ann Surg Oncol; 2012 Oct; 19(10):3199-204. PubMed ID: 22766989
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of early-stage synchronous bilateral invasive breast cancer.
Schmid SM; Pfefferkorn C; Myrick ME; Viehl CT; Obermann E; Schötzau A; Güth U
Eur J Surg Oncol; 2011 Jul; 37(7):623-8. PubMed ID: 21628090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
